Henry M Kronenberg Selected Research

Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)

1/2020	PTH/PTHrP Receptor Signaling Restricts Arterial Fibrosis in Diabetic LDLR-/- Mice by Inhibiting Myocardin-Related Transcription Factor Relays.
7/2008	Osteopontin negatively regulates parathyroid hormone receptor signaling in osteoblasts.
8/2007	Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption.
4/2006	PTH/PTHrP receptor delays chondrocyte hypertrophy via both Runx2-dependent and -independent pathways.
10/2004	Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo.
8/2002	The PTH/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henry M Kronenberg Research Topics

Disease

9	Hypertrophy 01/2021 - 08/2002
8	Osteoporosis 01/2021 - 09/2005
3	Bone Resorption 01/2021 - 03/2004
3	Fibrosis (Cirrhosis) 01/2020 - 02/2010
2	Bone Diseases (Bone Disease) 01/2016 - 04/2013
2	Hyperparathyroidism 08/2010 - 02/2010
2	Hypoxia (Hypoxemia) 05/2007 - 10/2004
1	Pain (Aches) 01/2022
1	Chondroma (Enchondroma) 01/2021
1	Metabolic Bone Diseases (Osteopenia) 01/2021
1	Osteochondroma (Osteocartilaginous Exostosis) 01/2021
1	Arteriosclerosis 01/2020
1	Leukemia 01/2020
1	Primary Failure of Tooth Eruption 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2016
1	Neoplasms (Cancer) 01/2016
1	Hypocalcemia 08/2015
1	Multiple Myeloma 04/2013
1	Osteitis 02/2010
1	Carcinogenesis 08/2009
1	Inflammation (Inflammations) 08/2009
1	Arthritis (Polyarthritis) 08/2009
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2009
1	MASS syndrome 07/2008

Drug/Important Bio-Agent (IBA)

10	Parathyroid Hormone-Related ProteinIBA 01/2021 - 09/2005
6	Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA 01/2020 - 08/2002
6	Parathyroid Hormone (Parathormone)IBA 01/2020 - 09/2009
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2008
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2006
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2021
2	MEF2 Transcription FactorsIBA 01/2021 - 01/2019
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 01/2019
2	SaltsIBA 01/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2019 - 03/2004
2	MineralsIBA 03/2016 - 01/2016
2	Neutralizing AntibodiesIBA 01/2016 - 04/2013
2	CalciumIBA 08/2015 - 02/2010
2	beta CateninIBA 04/2009 - 06/2008
1	Biological FactorsIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	FluoridesIBA 01/2022
1	Denosumab FDA Link 01/2022
1	1-Carboxyglutamic Acid (1 Carboxyglutamic Acid)IBA 01/2021
1	YKL-05-099IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	myocardinIBA 01/2020
1	Anabolic AgentsIBA 01/2018
1	Teriparatide (Parathar)FDA Link 09/2017
1	Hormones (Hormone)IBA 03/2016
1	Proteasome InhibitorsIBA 01/2016
1	Pharmaceutical PreparationsIBA 03/2015
1	Collagen Type I (Type I Collagen)IBA 02/2012
1	Green Fluorescent ProteinsIBA 02/2012
1	starlicideIBA 08/2010
1	Extracellular Matrix ProteinsIBA 08/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2009
1	GranulinsIBA 08/2009
1	Metalloproteases (Metalloproteinases)IBA 08/2009
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 06/2008
1	cyclopamineIBA 06/2008
1	deoxypyridinolineIBA 08/2007
1	Oxygen (Dioxygen)IBA 05/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2004
1	RANK LigandIBA 03/2004
1	Type C PhospholipasesIBA 08/2002

Therapy/Procedure

4	Therapeutics 01/2021 - 07/2015
1	Bone Lengthening 01/2021